VOLORIDGE INVESTMENT MANAGEMENT, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,826,008
+205.6%
102,503
+233.2%
0.01%
+250.0%
Q2 2023$924,616
-45.7%
30,759
-51.9%
0.00%
-63.6%
Q3 2021$1,704,000
+13.6%
63,894
+11.5%
0.01%0.0%
Q1 2021$1,500,000
-54.2%
57,283
-56.0%
0.01%
-59.3%
Q4 2020$3,275,000
+4.9%
130,168
-13.1%
0.03%
+3.8%
Q3 2020$3,122,000
-8.1%
149,800
+4.8%
0.03%
-33.3%
Q2 2020$3,396,000
+40.5%
143,001
+6.4%
0.04%
-43.5%
Q1 2020$2,417,000
+43.0%
134,339
+88.6%
0.07%
+109.1%
Q4 2019$1,690,000
+225.6%
71,229
+277.1%
0.03%
+266.7%
Q3 2019$519,000
-53.2%
18,888
-43.6%
0.01%
-71.0%
Q2 2019$1,109,000
+7.4%
33,516
+13.7%
0.03%0.0%
Q1 2019$1,033,000
-23.9%
29,479
-27.8%
0.03%
-50.0%
Q4 2018$1,357,000
-32.8%
40,842
+21.0%
0.06%
+14.8%
Q2 2018$2,020,000
+59.3%
33,753
+14.8%
0.05%
+68.8%
Q2 2017$1,268,00029,4120.03%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders